(Q38450375)

3 September 2017

title

HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma (English)

1 reference

fluorescence in situ hybridization

3 September 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579298

25 March 2024

1 reference

25 March 2024

1

Cecilia Bozzetti

1 reference

3 September 2017

2

Nicola Personeni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579298

25 March 2024

7

Francesca Negri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579298

25 March 2024

11

Stefano Cascinu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579298

25 March 2024

author name string

Rita Nizzoli

3

1 reference

3 September 2017

Annamaria Guazzi

4

1 reference

3 September 2017

Marcella Flora

5

1 reference

3 September 2017

Cristina Bassano

6

1 reference

3 September 2017

Eugenia Martella

8

1 reference

3 September 2017

Nadia Naldi

9

1 reference

3 September 2017

Vittorio Franciosi

10

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

3 September 2017

25 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14579298

full work available at URL

25 March 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11731

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579298

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11731

25 March 2024

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11731

25 March 2024

1 reference

25 March 2024

1 reference

3 September 2017

volume

99

1 reference

3 September 2017

issue

5

1 reference

3 September 2017

page(s)

310-315

1 reference

describes a project that uses

3 September 2017

fluorescence in situ hybridization

1 reference

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Stability of HER-2/neu expression over time and at multiple metastatic sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Applications of fluorescence in situ hybridization techniques in cytopathology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Detection of c-erbB-2 (HER-2/neu) amplification in breast carcinoma by fluorescence in situ hybridization on tissue sections and imprinted cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11731

7 January 2021

Increased erbB-2 gene copies and expression in multiple stages of breast cancer

5

1 reference

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

25 March 2024

8

1 reference

25 March 2024

Identifiers

DOI

10.1002/CNCR.11731

1 reference

3 September 2017

1 reference